Larvol Delta - Isunakinra-Alone-and-in-Combination-With-a-PD1PDL1-Inhibitor-in-Patients-With-Solid-Tumors

isunakinra (EBI-005) - Sesen Bio

http://clinicaltrials.gov/ct2/show/NCT04121442

Sep 4, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next